NanoString Technologies

President and Chief Executive Officer

Brad Gray joined NanoString from Genzyme Genetics, the diagnostic services division of Genzyme Corporation, where he was most recently Vice President of Product & Business Development leading the development of molecular diagnostics and partnering activities.  Mr. Gray held several strategy and business development roles at the corporate and division levels beginning in 2004 when he joined Genzyme Corporation as Director of Corporate Development. Previously, Mr. Gray was a management consultant in the healthcare practice of McKinsey & Company. He holds a B.A. in Economics and Management from Oxford University, where he studied as a British Marshall Scholar, and an S.B. in Chemical Engineering from the Massachusetts Institute of Technology.